Hjem › Dermatomyositt › North Carolina › Durham
Kliniske studier for Dermatomyositt i Durham, NC
8 studier for Dermatomyositt søker deltakere på steder i og rundt Durham (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Environmental Risk Factors for the Anti-synthetase Syndrome
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- NIEHS Clinical Research Unit (CRU), Research Triangle Park · 7 mi unna
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
RekruttererFase 3
- Research Site, Durham
Adult and Juvenile Myositis
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- NIEHS Clinical Research Unit (CRU), Research Triangle Park · 7 mi unna
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
RekruttererFase 2/3
- Duke University Medical Center - Accepting Young Adults and Juvenile Patients, Durham
- University of North Carolina at Chapel Hill - Accepting Adult Patients, Chapel Hill · 10 mi unna
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
RekruttererFase 1
- Research Site, Chapel Hill · 10 mi unna
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
RekruttererFase 1
- Duke University Medical Center, Durham
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
RekruttererFase 1
- Universtity of North Carolina at Chapel Hill, Chapel Hill · 10 mi unna
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
RekruttererFase 1
- Duke University, Durham
Dermatomyositt-studier i andre byer
- Washington, DC7 studier
- New York City, NY5 studier
- Pittsburgh, PA5 studier
- Boston, MA5 studier
- Houston, TX5 studier
- Philadelphia, PA4 studier
- Baltimore, MD4 studier
- Miami, FL4 studier
- Cleveland, OH3 studier
- Jacksonville, FL3 studier
- Aurora, CO3 studier
- Kansas City, KS3 studier
Andre studier i Durham
- Brystkreft63 studier
- Kreft (alle typer)58 studier
- Ikke-småcellet lungekreft39 studier
- Multipelt myelom37 studier
- Metastatisk kreft33 studier
- Akut myelogen leukemi33 studier
- Lungekreft32 studier
- Prostatakreft32 studier
- Kolorektal kreft28 studier
- Kronisk lymfatisk leukemi27 studier
- Eggstokkreft27 studier
- Hjertesvikt26 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.